JUPITER BIOSCIENCE LTD.

NSE : NABSE : 524826ISIN CODE : INE918B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.970 (0 %)
PREV CLOSE ( ) 3.97
OPEN PRICE ( ) 4.06
BID PRICE (QTY) 4.11 (2390)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 230737
TODAY'S LOW / HIGH ( )3.89 4.14
52 WK LOW / HIGH ( ) 3.894.14
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2011Mar2010Mar2009Mar2008Mar2007
Profit Before Tax582.82490.66377.51344.60270.58
Adjustment945.25739.92537.54376.27281.35
Changes In working Capital-232.86-225.78-191.09-204.25-296.96
Cash Flow after changes in Working Capital1295.211004.80723.97516.61254.97
Cash Flow from Operating Activities1175.40921.05681.19477.67177.58
Cash Flow from Investing Activities-5143.98-2201.53-1431.95-1632.07-1046.87
Cash Flow from Financing Activities3947.081329.17742.621153.50879.88
Net Cash Inflow / Outflow-21.4948.69-8.13-0.9010.59
Opening Cash & Cash Equivalents64.4215.7323.8624.7614.17
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent42.9264.4215.7323.8624.76

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.